Advances in immunotherapy and targeted therapy for nasopharyngeal carcinoma: Current progress and combined approaches (Review).

Oncol Rep · 2026 · PMC12957904 · PMID 41789645

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a clear trendno p-value reported

In addition, a clear trend toward survival benefit was observed in OS, particularly after excluding the interference of crossover treatments, where this advantage became even more pronounced.

also in 19,460 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.